Prokidney (PROK) Interest Expenses (2021 - 2026)

Prokidney (PROK) reported Interest Expenses of $15000.0 for Q1 2026, up 1400.0% quarter-over-quarter from $1000.0 in Q4 2025.

Prokidney (PROK) Interest Expenses (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Interest Expenses data on file, last reported at $15000.0 in Q1 2026.

  • Interest Expenses for Q1 2026 came in at $15000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $19000.0 (up 171.43% YoY), and the FY2025 annual result was $4000.0, down 55.56% from the prior year.
  • Interest Expenses advanced to $15000.0 in Q1 2026 per PROK's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $170000.0 in Q2 2022 and troughed at $1000.0 in Q2 2025.
  • A 5-year average of $15937.5 and a median of $2500.0 in 2022 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2022 and 2023: Interest Expenses soared 2800.0% in 2022, then plunged 97.65% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $2000.0 in 2022, then soared by 50.0% to $3000.0 in 2023, then tumbled by 33.33% to $2000.0 in 2024, then sank by 50.0% to $1000.0 in 2025, then jumped by 1400.0% to $15000.0 in 2026.
  • Business Quant data shows PROK's Interest Expenses at $15000.0 in Q1 2026, $1000.0 in Q4 2025, and $2000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Prokidney 259.01 Mn 1.55 Bn - 15,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 15,000.00
Mar 31, 2026 15,000.00
Dec 31, 2025 1,000.00
Dec 31, 2025 1,000.00
Sep 30, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Dec 31, 2024 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 3,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 2,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 3,000.00
Dec 31, 2023 3,000.00
Sep 30, 2023 2,000.00
Sep 30, 2023 2,000.00